Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis?

Epilepsia

Volumn 51, Issue SUPPL. 3, 2010, Pages 48-51

  Simonato, Michele ^a   Zucchini, Silvia ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Epileptogenesis; Gene therapy; Neurogenesis; Neurotrophic factors; Viral vectors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; VIRUS VECTOR;

CELL LOSS; CONFERENCE PAPER; EPILEPTIC STATE; EPILEPTOGENESIS; NERVE DEGENERATION; NERVE INJURY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTICONVULSANTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; EPILEPSY, POST-TRAUMATIC; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENETIC VECTORS; HIPPOCAMPUS; HUMANS; NERVE GROWTH FACTORS;

EID: 77954504218     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02609.x     Document Type: Conference Paper

References (18)

1. Binder DK, Croll SD, Gall CM, Scharfman HE. (2001) BDNF and epilepsy: too much of a good thing? Trends Neurosci 24:47-53.
2. Hagg T. (2005) Molecular regulation of adult CNS neurogenesis: an integrated view. Trends Neurosci 28:589-595.
3. He XP, Kotloski R, Nef S, Luikart BW, Parada LF, McNamara JO. (2004) Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43:31-42.
4. Kempermann G. (2006) They are not too excited: the possible role of adult-born neurons in epilepsy. Neuron 52:935-937.
5. Marconi P, Simonato M, Zucchini S, Bregola G, Argnani R, Krisky D, Glorioso JC, Manservigi R. (1999) Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo. Gene Ther 6:904-912.
6. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M. (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110:429-441.
7. Palma E, Torchia G, Limatola C, Trettel F, Arcella A, Cantore G, Di Gennaro G, Manfredi M, Esposito V, Quarato PP, Miledi R, Eusebi F. (2005) BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes. Proc Natl Acad Sci U S A 102:1667-1672. (Pubitemid 40209225)
8. Paradiso B, Marconi P, Zucchini S, Berto E, Binaschi A, Bozac A, Buzzi A, Mazzuferi M, Magri E, Navarro Mora G, Rodi D, Su T, Volpi I, Zanetti L, Marzola A, Manservigi R, Fabene PF, Simonato M. (2009) Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci U S A 106:7191-7196.
9. Pitkanen A, Sutula TP. (2002) Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 1:173-181.
10. Pitkänen A, Kubova H. (2004) Antiepileptic drugs in neuroprotection. Expert Opin Pharmacother 5:777-798.
11. Racine RJ. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
12. Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S. (2005) Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol 192: 348-356.
13. Simonato M, Manservigi R, Marconi P, Glorioso J. (2000) Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors. Trends Neurosci 23:183-190.
14. Simonato M, Tongiorgi E, Kokaia M. (2006) Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci 27:631-638.
15. Sloviter RS. (2005) The neurobiology of temporal lobe epilepsy: too much information, not enough knowledge. C R Biol 328:143-153.
16. Xu B, Michalski B, Racine RJ, Fahnestock M. (2004) The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes. Neuroscience 126:521-531.
17. Zucchini S, Barbieri M, Simonato M (2005) Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the fibroblast growth factor-2 system. Epilepsia 46 (S5):52-58. (Pubitemid 40962122)
18. Zucchini S, Buzzi A, Barbieri M, Rodi D, Paradiso B, Binaschi A, Coffin JD, Marzola A, Cifelli P, Belluzzi O, Simonato M. (2008) FGF-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss. J Neurosci 28:13112-13124.